Three complete growth-hormone-secretagogue consents in one pack — each with its own current regulatory story, from Sermorelin's discontinued-approval history to the 2026 FDA compounding review that CJC-1295 and ipamorelin are still moving through.
Secure checkout on Etsy · instant download · lifetime updates
Every document: editable placeholders for your practice name and providers · US Letter + A4 · educational-template disclaimer included.
The complete documentation system for peptide practices: five substance-specific informed consents (BPC-157, CJC-1295/Ipamorelin, Sermorelin, NAD+, Glutathione),…
Substance-specific informed consent for NAD+ injections and infusions — including rate-dependent infusion reactions and honest compounded-medication language.
An honest, thorough BPC-157 consent: investigational status, FDA compounding category history, unknown long-term effects — the disclosure serious clinics actually…